Document is current
Any future updates will be listed below
-
Authors
Lin, Yinbing
Yang, Zhining
Chen, Jiechen
Li, Mei
Cai, Zeman
Wang, Xiao
Zhai, Tiantian
Lin, Zhixiong https://orcid.org/0000-0003-4898-7441
-
Funding
Funding for this research was provided by:
National Nature Science Foundation of China (82003221)
Department of Education of Guangdong Province (2019KQNCX032)
Science and technology projects of Shantou (200601155261081)
Science and Technology Special Fund of Guangdong Province of China (2018-49)
National Defense Science and Technology Innovation Fund of the Chinese Academy of Sciences (2019-132)
- License Information
-
More Information
Article History
Received: 16 November 2022
Revised: 5 June 2023
Accepted: 12 June 2023
First Online: 18 August 2023
Declarations
:
: The scientific guarantor of this publication is Zhixiong Lin.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: The Faculty of Medical Statistics at Shantou University Medical College kindly provided statistical advice for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial. (PMID: 33955190).
: • retrospective• diagnostic or prognostic study• performed at one institution
